CELEX: 62019TN0264
Language: en
Date: 2019-04-18 00:00:00
Title: Case T-264/19: Action brought on 18 April 2019 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover)

17.6.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 206/94
            
         
      Action brought on 18 April 2019 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover)
      (Case T-264/19)
      (2019/C 206/83)
      Language in which the application was lodged: German
      
         Parties
      
      
         Applicant: nanoPET Pharma GmbH (Berlin, Germany) (represented by: C. Onken, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Miltenyi Biotec GmbH (Bergisch Gladbach, Germany)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: EU figurative mark ‘viscover’ — EU trade mark No 9 197 732
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 17 January 2019 in Case R 1288/2017-5
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  order EUIPO to pay the costs.
               
            
         Pleas in law
      
      
                  —
               
               
                  Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;
               
            
                  —
               
               
                  Infringement of Article 60(2)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.